U.S. Gas Utilities Stock News

Mobileye Global (MBLY) has drawn fresh attention after Q1 2026 results showed 27% year over year revenue growth, higher full year guidance, a US$250 million share repurchase plan, and progress on programs with Volkswagen and Mahindra. See our latest analysis for Mobileye Global. The stock has been volatile, with a 1 month share price return of 29.79% and a 7 day return of 9.03% after the Q1 beat, raised guidance, and buyback announcement. However, the year to date share price is still down...

In early May 2026, Rhythm Pharmaceuticals reported first-quarter revenue of US$60.11 million and a net loss of US$55.64 million, while also securing European Commission approval to expand IMCIVREE (setmelanotide) for acquired hypothalamic obesity and presenting longer-term efficacy and safety data across pediatric and adult populations. The new data presentations and broadened regulatory label for setmelanotide highlight growing clinical evidence in rare neuroendocrine obesity disorders and...

Millicom International Cellular’s first-quarter 2026 results, released earlier this week, showed revenue rising to US$1.99 billion from US$1.37 billion a year earlier, while net income declined to US$109 million and earnings per share fell to US$0.65 amid higher restructuring and integration costs. The quarter underlined how recent acquisitions across Colombia, Chile, Ecuador, and Uruguay are rapidly expanding Millicom’s scale and service revenues, but also increasing leverage and near-term...

Neogen recently presented at the 2nd Annual Spring One-on-One Virtual Conference on May 13, 2026, while new regulatory filings showed Clarkston Capital Partners holds a passive 1.01% stake in the company through discretionary client accounts. Minot Light Capital Partners and its Capital Appreciation Fund both cited Neogen as a top contributor in Q1 2026, highlighting new management, asset sales, and balance sheet improvements as key elements in its post-3M food safety merger recovery...

CuriosityStream (CURI) opened 2026 with Q1 revenue of US$15.2 million and a basic EPS loss of US$0.02, while trailing 12 month revenue stood at US$71.7 million and basic EPS over that period was a loss of US$0.14. The company has seen quarterly revenue move from US$14.1 million in Q4 2024 to a range between US$15.1 million and US$19.2 million across 2025, with basic EPS shifting between a profit of US$0.01 and losses of up to US$0.06. This sets up a results season where the focus is squarely...

SciTec, a subsidiary of Firefly Aerospace, has secured a new contract with the Air Force Research Laboratory focused on advanced algorithms for defense. The work centers on deep learning and sensor technologies that support U.S. defense applications. This contract highlights Firefly Aerospace's growing involvement in AI powered aerospace solutions. For investors watching Firefly Aerospace, NasdaqGM:FLY, the contract with the Air Force Research Laboratory arrives after a strong share price...

Wondering whether First Solar's current price gives you enough value for the risk you are taking? This article focuses squarely on what the numbers say about the stock's valuation. First Solar last closed at US$233.37, with the stock showing returns of 6.1% over 7 days, 19.6% over 30 days and 30.8% over 1 year, while the year-to-date return is a decline of 14.9%. These moves sit against a backdrop of continued investor attention on solar and semiconductor related stocks, where capital...

WhiteFiber, Inc. has reported its Q1 2026 results, with revenue rising to US$21.92 million while the company moved from a prior net profit to a US$12.04 million net loss and a basic loss per share of US$0.31. Alongside earnings, WhiteFiber accelerated its data center and AI infrastructure buildout, funded partly by US$230 million of 4.50% convertible senior notes and the purchase of additional facility ownership to support future capacity. Next, we’ll examine how this loss-making quarter,...

Figma (FIG) opened Q1 2026 with total revenue of US$333.4 million and a basic EPS loss of US$0.27, while trailing 12 month revenue reached US$1.2 billion against a trailing EPS loss of US$3.38 and year on year revenue growth of 41.4%. Over recent quarters, the company has seen revenue move from US$216.9 million in Q4 2024 to US$333.4 million in Q1 2026. Quarterly EPS has swung between a profit of US$0.46 in Q4 2024 and a loss of US$2.72 in Q3 2025 before landing at a loss of US$0.27 this...

Empire Petroleum (EP) opened 2026 with Q1 revenue of about US$5.1 million and a basic EPS loss of US$0.18, while the trailing twelve months show revenue of roughly US$30.3 million and a basic EPS loss of US$2.15. Over recent quarters the company has seen revenue move from US$12.97 million in Q4 2024 to US$9.00 million in Q1 2025 and US$5.10 million in Q1 2026, alongside a shift in quarterly basic EPS losses from US$0.13 to US$0.12 and then US$0.18. This keeps the focus on how efficiently each...

Harmony Biosciences Holdings, Inc. reported past first-quarter 2026 results on May 7, with net income of US$32.49 million, down from US$45.56 million a year earlier, and basic earnings per share from continuing operations of US$0.56 versus US$0.79. Alongside this earnings miss, the company highlighted 17% net product revenue growth, fresh FDA approval for a pediatric cataplexy indication, and active legal efforts to protect WAKIX patents into 2030. We’ll now examine how robust revenue growth...

Earlier this week, JD.com reported first-quarter 2026 results showing revenue of CNY 315.69 billion and net income of CNY 5.10 billion, with earnings per share from continuing operations roughly halving year on year. At the same time, JD.com completed a major buyback program repurchasing 227.70 million shares, about 15.87% of its share base, signaling management’s confidence while it invests in automation, AI logistics, and higher-margin services. Next, we’ll examine how JD.com’s strong Q1...

Ingredion (NYSE:INGR) has entered takeover talks to acquire Tate & Lyle in an all cash deal. The potential transaction is valued at about US$3.7b and would combine two major players in sweeteners and specialty food ingredients. The discussions confirm a formal approach, although there is no announced agreement or timeline for completion. For investors watching NYSE:INGR, this move centers on core products like sweeteners, starches, and specialty ingredients that feed into food, beverage,...

If you are wondering whether Wix.com at US$52.71 is starting to look like value or still carries too much risk, the recent share price performance gives you plenty to think about. The stock has fallen 34.4% over the past week, 17.4% over the last month, 47.8% year to date, 71.2% over one year, 34.7% over three years, and 78.7% over five years, which may change how you think about its potential and the risks involved. Recent coverage around Wix.com has focused on how the stock's sharp...

Aeluma (NasdaqCM:ALMU) has just posted its Q3 2026 numbers, reporting revenue of US$1.2 million and a loss of US$1.8 million, or EPS of US$0.10. This sets a cautious tone for shareholders at the current US$26.65 share price. Over recent quarters the company has reported revenue between US$1.3 million and US$1.6 million, while EPS has shifted from a profit of US$0.12 in Q3 2025 to losses of around US$0.09 to US$0.24 per share. This has kept margins under clear pressure and made profitability...

Axsome Therapeutics (AXSM) is back in focus after detailing plans to launch AUVELITY for Alzheimer’s disease agitation in June, supported by a larger sales force and expectations of broad Medicare Part D coverage. See our latest analysis for Axsome Therapeutics. The June AUVELITY launch plan for Alzheimer’s agitation and recent first quarter 2026 earnings have arrived alongside strong momentum, with a 30 day share price return of 26.11% and a one year total shareholder return of 116.63%. If...

Concentrix (CNXC) is back in focus as investors weigh its upcoming appearance at the Needham Technology, Media, & Consumer Conference in light of ongoing worries about AI disruption, softer growth trends, and higher leverage from the Webhelp acquisition. See our latest analysis for Concentrix. The recent share price tells a cautious story, with Concentrix at US$23.42 after a 1 month share price return down 17.19% and year to date share price return down 43.17%. This mirrors a 1 year total...

Tron Inc. reported first-quarter 2026 results, with sales of US$1.18 million versus US$1.09 million a year earlier and net income of US$21.63 million compared with a net loss in the prior-year period. This shift from a loss per share to positive basic earnings per share from continuing operations highlights a sharp improvement in Tron's profitability profile. We will now examine how Tron's return to profitability in the latest quarter shapes the company's broader investment narrative and...

Omeros (OMER) opened 2026 with Q1 revenue of US$9.9 million and basic EPS of US$0.71, alongside net income from continuing operations of US$51.2 million, setting a clear earnings focused tone for the quarter. Over recent periods, the company has seen quarterly revenue move from US$0 to US$9.9 million while quarterly EPS has ranged from a loss of US$0.65 to a gain of US$1.13, giving investors a wide band of outcomes to weigh as they assess how much of the latest profit is repeatable versus...

Doximity (DOCS) has just wrapped up FY 2026 with Q4 revenue of US$145.4 million and basic EPS of US$0.10, while trailing twelve month revenue stood at US$644.9 million and EPS at US$1.05. Over recent periods, the company has seen quarterly revenue move between US$138.3 million and US$185.1 million, with basic EPS ranging from US$0.28 to US$0.40, setting the backdrop for a trailing net profit margin that sits at 30.4% versus 39.1% a year earlier. For investors, the latest earnings print is...

Kinsale Capital Group recently declared a US$0.25 per-share cash dividend, payable on June 11, 2026 to shareholders of record on May 28, 2026, while also reporting first-quarter 2026 earnings that exceeded analyst expectations. The company’s 10-year streak of dividend increases, including very large dividend growth over the past year, highlights a sustained focus on shareholder returns alongside its specialty excess and surplus insurance operations. We’ll now examine how Kinsale’s...

Birkenstock Holding (NYSE:BIRK) has just posted Q2 2026 results with revenue of €618.3 million and basic EPS of €0.45, set against trailing twelve month revenue of about €2.2 billion and EPS of €1.93. This coincided with net profit margin moving to 16.3% from 12.9% and earnings growth of 40.9% over the past year. Over recent quarters, the company has seen revenue move from €574.3 million and EPS of €0.56 in Q2 2025 to €618.3 million and €0.45 in Q2 2026. At the same time, trailing EPS has...

Murphy USA (MUSA) has drawn investor attention after recent share price moves, with the stock last closing at US$576.20 and showing mixed short term returns alongside relatively stronger performance over the past 3 months and year. See our latest analysis for Murphy USA. While the share price has eased in the very short term, the 30 day share price return of 15.60% and strong multi year total shareholder returns, including 322.33% over five years, point to momentum that has built over time as...

Wondering if Credo Technology Group Holding at US$184.54 is priced for perfection or still offers value? This article walks through the key signals you need to weigh. The stock has pulled back about 2% over the past week, yet it is still up 15.7% over 30 days, 28.9% year to date and 209.7% over the past year. These moves sit against a backdrop of ongoing interest in semiconductor and connectivity stocks, with Credo Technology Group Holding often cited in market commentary as part of the high...